QTTB
Income statement / Annual
Last year (2024), Q32 Bio Inc.'s total revenue was $0.00,
a decrease of 100.00% from the previous year.
In 2024, Q32 Bio Inc.'s net income was -$47.73 M.
See Q32 Bio Inc.,s key income statements, including revenue, expenses, profit, and income.
| Period |
FY-2024
|
FY-2023
|
FY-2022
|
FY-2021
|
FY-2020
|
FY-2019
|
FY-2018
|
FY-2017
|
FY-2016
|
| Period Ended |
12/31/2024 |
12/31/2023 |
12/31/2022 |
12/31/2021 |
12/31/2020 |
12/31/2019 |
12/31/2018 |
12/31/2017 |
12/31/2016 |
| Operating Revenue |
$0.00 |
-$6.65 M |
$6.65 M |
$33.97 M |
$2.70 M |
$1.67 M |
$5.32 M |
$0.00 |
$0.00 |
| Cost of Revenue |
$487.00 K
|
$578.00 K
|
$2.60 M
|
$9.54 M
|
$0.00
|
$0.00
|
$0.00
|
$684.21 K
|
$239.80 K
|
| Gross Profit |
-$487.00 K
|
-$7.23 M
|
$4.05 M
|
$24.43 M
|
$2.70 M
|
$1.67 M
|
$5.32 M
|
-$684.21 K
|
-$239.80 K
|
| Gross Profit Ratio |
0
|
1.09
|
0.61
|
0.72
|
1
|
1
|
1
|
0
|
0
|
| Research and Development Expenses |
$48.14 M
|
$31.73 M
|
$35.81 M
|
$29.93 M
|
$100.39 M
|
$89.40 M
|
$47.95 M
|
$21.38 M
|
$5.69 M
|
| General & Administrative Expenses |
$0.00
|
$9.88 M
|
$10.06 M
|
$6.76 M
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
| Selling & Marketing Expenses |
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
| Selling, General & Administrative Expenses |
$17.47 M
|
$9.88 M
|
$10.06 M
|
$6.76 M
|
$23.67 M
|
$15.89 M
|
$16.01 M
|
$7.60 M
|
$4.07 M
|
| Other Expenses |
$0.00
|
$0.00
|
-$1.12 M
|
-$324.00 K
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
| Operating Expenses |
$65.62 M
|
$41.60 M
|
$45.88 M
|
$36.69 M
|
$124.06 M
|
$105.29 M
|
$63.96 M
|
$28.97 M
|
$9.76 M
|
| Cost And Expenses |
-$66.10 M
|
$41.60 M
|
$45.88 M
|
$36.69 M
|
$132.97 M
|
$111.61 M
|
$65.25 M
|
$29.66 M
|
$10.00 M
|
| Interest Income |
$3.90 M
|
$0.00
|
$0.00
|
$0.00
|
$1.57 M
|
$6.03 M
|
$4.35 M
|
$542.64 K
|
$24.20 K
|
| Interest Expense |
$300.00 K
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
| Depreciation & Amortization |
$487.00 K
|
$499.00 K
|
$2.60 M
|
$9.54 M
|
$8.90 M
|
$6.32 M
|
$1.29 M
|
$684.21 K
|
$239.80 K
|
| EBITDA |
-$45.30 M |
-$47.76 M |
-$38.86 M |
-$86.22 M |
-$121.36 M |
-$103.63 M |
-$58.64 M |
-$29.31 M |
-$7.81 M |
| EBITDA Ratio |
0
|
7.18
|
-5.84
|
-2.54
|
-44.91
|
-62.2
|
-11.02
|
0
|
0
|
| Operating Income Ratio |
0
|
7.26
|
-5.9
|
-1.08
|
-48.21
|
-65.99
|
-11.26
|
0
|
0
|
| Total Other Income/Expenses Net |
$20.02 M
|
-$5.17 M
|
-$3.52 M
|
-$324.00 K
|
$1.57 M
|
$6.03 M
|
$4.35 M
|
-$333.37 K
|
$1.95 M
|
| Income Before Tax |
-$46.09 M
|
-$53.43 M
|
-$42.75 M
|
-$37.02 M
|
-$128.69 M
|
-$103.92 M
|
-$55.58 M
|
-$29.99 M
|
-$8.05 M
|
| Income Before Tax Ratio |
0
|
8.03
|
-6.43
|
-1.09
|
-47.63
|
-62.37
|
-10.44
|
0
|
0
|
| Income Tax Expense |
$21.00 K
|
$318.00 K
|
$62.00 K
|
$547.00 K
|
$0.00
|
$0.00
|
$0.00
|
-$4.00
|
$2.00
|
| Net Income |
-$47.73 M
|
-$53.74 M
|
-$42.81 M
|
-$37.56 M
|
-$128.69 M
|
-$103.92 M
|
-$55.58 M
|
-$29.99 M
|
-$8.05 M
|
| Net Income Ratio |
0
|
8.08
|
-6.44
|
-1.11
|
-47.63
|
-62.37
|
-10.44
|
0
|
0
|
| EPS |
-5.12 |
-4.51 |
-13.42 |
-12.23 |
-50.46 |
-44.41 |
-35.04 |
-14.42 |
-3.87 |
| EPS Diluted |
-6.58 |
-4.51 |
-13.42 |
-12.23 |
-50.46 |
-44.41 |
-35.04 |
-14.42 |
-3.87 |
| Weighted Average Shares Out |
$9.32 M
|
$11.93 M
|
$3.19 M
|
$3.07 M
|
$2.55 M
|
$2.34 M
|
$1.59 M
|
$2.08 M
|
$2.08 M
|
| Weighted Average Shares Out Diluted |
$9.66 M
|
$11.93 M
|
$3.19 M
|
$3.07 M
|
$2.55 M
|
$2.34 M
|
$1.59 M
|
$2.08 M
|
$2.08 M
|
| Link |
|
|
|
|
|
|
|
|
|
